165 related articles for article (PubMed ID: 7134717)
21. Diagnosing hypovitaminosis D: serum measurements of calcium, phosphate, and alkaline phosphatase are unreliable, even in the presence of secondary hyperparathyroidism.
Smith GR; Collinson PO; Kiely PD
J Rheumatol; 2005 Apr; 32(4):684-9. PubMed ID: 15801026
[TBL] [Abstract][Full Text] [Related]
22. [Collagen metabolism in hyperthyroidism].
Rommel K; Fourie L; Böhm W; Adam WE; Benecke G
Med Klin; 1968 Mar; 63(11):410-3. PubMed ID: 4177533
[No Abstract] [Full Text] [Related]
23. [Osteoporosis in Cushing's syndrome].
Tomita A; Takatsuki K
Nihon Rinsho; 1990 Dec; 48(12):2877-81. PubMed ID: 2086848
[No Abstract] [Full Text] [Related]
24. [Sodium etidronate (EHDP) and osteoporosis].
Nuti R; Righi G; Turchetti V; Vattimo A
Clin Ter; 1981 Oct; 99(1):33-42. PubMed ID: 6171376
[No Abstract] [Full Text] [Related]
25. The effect of raloxifene on markers of bone turnover in older women living in long-term care facilities.
Hansdóttir H; Franzson L; Prestwood K; Sigurdsson G
J Am Geriatr Soc; 2004 May; 52(5):779-83. PubMed ID: 15086661
[TBL] [Abstract][Full Text] [Related]
26. [Prolactin and estrogens in osteoporosis in post-menopausal women (author's transl)].
Rico Lenza H
Med Clin (Barc); 1982 May; 78(9):372-5. PubMed ID: 7098615
[No Abstract] [Full Text] [Related]
27. [Primary osteoporosis: pathogenesis, diagnosis and treatment].
Gasińska T
Pol Tyg Lek; 1973 Dec; 28(50):1984-7. PubMed ID: 4589065
[No Abstract] [Full Text] [Related]
28. Effect of fluoride therapy on nondialyzable urinary hydroxyproline, serum alkaline phosphatase, parathyroid hormone, and 25-hydroxyvitamin D.
Manzke E; Rawley R; Vose G; Roginsky M; Rader JI; Baylink DJ
Metabolism; 1977 Sep; 26(9):1005-10. PubMed ID: 895531
[No Abstract] [Full Text] [Related]
29. Treatment of osteoporosis with calcium infusions.
Pak CY; Bartter FC
Semin Drug Treat; 1972; 2(1):39-46. PubMed ID: 5048563
[No Abstract] [Full Text] [Related]
30. [Biological markers of bone turnover in renal failure].
Ureña P
Ann Biol Clin (Paris); 2001; 59(3):313-6. PubMed ID: 11397681
[No Abstract] [Full Text] [Related]
31. Mineral intake and bone loss.
Hegsted DM
Fed Proc; 1967; 26(6):1747-54. PubMed ID: 4864748
[No Abstract] [Full Text] [Related]
32. [Correlations between hydroxyprolinuria and kinetic parameters (Ca45) in bone diseases].
Gruson M; Miravet L; Hioco D
Ann Biol Clin (Paris); 1967; 25(5):711-24. PubMed ID: 6059730
[No Abstract] [Full Text] [Related]
33. Calcium metabolism and its regulating hormones in patients with leprosy.
Mautalen CA; Vaquero NL; Zeni SN; Mendez MA; Gonzalez DC; Bagur AC; Casco CA; Ladizesky MG
Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):580-5. PubMed ID: 7868957
[TBL] [Abstract][Full Text] [Related]
34. [Genetic polymorphism of vitamin D receptor and osteoporosis].
Sosa Henríquez M; Torres Ramírez A; Domínguez Cabrera C; Salido E; Saavedra Santana P; Barrios Y; Limiñana Cañal JM; Betancor León P
Med Clin (Barc); 1998 May; 110(17):646-50. PubMed ID: 9656208
[TBL] [Abstract][Full Text] [Related]
35. Changes of bone formation markers osteocalcin and bone-specific alkaline phosphatase in postmenopausal women with osteoporosis.
Lumachi F; Ermani M; Camozzi V; Tombolan V; Luisetto G
Ann N Y Acad Sci; 2009 Sep; 1173 Suppl 1():E60-3. PubMed ID: 19751416
[TBL] [Abstract][Full Text] [Related]
36. Metabolic studies and 47 Ca kinetics during high calcium intake in senile osteoporosis.
Caniggia A; Gennari C
Helv Med Acta; 1971 Dec; 36(1):43-50. PubMed ID: 5140809
[No Abstract] [Full Text] [Related]
37. High phosphorus intakes acutely and negatively affect Ca and bone metabolism in a dose-dependent manner in healthy young females.
Kemi VE; Kärkkäinen MU; Lamberg-Allardt CJ
Br J Nutr; 2006 Sep; 96(3):545-52. PubMed ID: 16925861
[TBL] [Abstract][Full Text] [Related]
38. [Biochemical markers of bone remodeling: pre-analytical variations and guidelines for their use. SFBC (Société Française de Biologie Clinique) Work Group. Biochemical markers of bone remodeling].
Garnero P; Bianchi F; Carlier MC; Genty V; Jacob N; Kamel S; Kindermans C; Plouvier E; Pressac M; Souberbielle JC
Ann Biol Clin (Paris); 2000; 58(6):683-704. PubMed ID: 11098165
[TBL] [Abstract][Full Text] [Related]
39. The action of 1alphahydroxy vitamin D3 and phosphate supplements in hypophosphataemic osteomalacia.
Peacock M; Aaron JE; Heyburn PJ; Nordin BE
Adv Exp Med Biol; 1977; 81():431-40. PubMed ID: 899935
[No Abstract] [Full Text] [Related]
40. The effect of vitamin D and phosphate on urinary total hydroxyproline excretion in adult-presenting "vitamin D resistant" type I renal tubular osteomalacia.
Smith R; Dick M
Clin Sci; 1968 Dec; 35(3):575-87. PubMed ID: 5705812
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
